Lisa Stiffler

Lisa Stiffler

Reporter at CoMotion News
Northwest United States

Lisa Stiffler is a journalist who covers nonprofits, companies, and researchers applying technology to environmental, energy, health, transit, education and other societal challenges; she has worked at the Seattle Post-Intelligencer, freelanced for The Seattle Times, and written for outlets including Seattle's Child, Sightline Institute, NPR, MSNBC, Smithsonian Magazine, GeekWire and CoMotion News.

Brian Pinkard Launches Aquagga to Destroy Toxic PFAS Chemicals, Deploys Device in Alaska in 2023

Brian Pinkard, driven by a passion to make an environmental impact, transitioned from trail building to earning a mechanical engineering PhD and founding Aquagga, a startup focused on destroying toxic PFAS 'forever chemicals'. His startup deployed a PFAS-destroying device in Fairbanks, Alaska in 2023, reflecting his commitment to solving critical pollution challenges.

Helion Energy Builds 166,000 Sq. Ft. Omega Facility and Commercial Fusion Plant to Scale Fusion Power Manufacturing

Helion Energy is advancing its seventh-generation fusion prototype while building a commercial power plant and a large-scale manufacturing facility named Omega to produce components for future fusion plants. The company emphasizes manufacturing and rapid growth, aiming to deliver fusion-generated electricity to the grid despite ongoing technology uncertainties.

Seattle Startup Singletto Launches FDA-Approved Virus-Killing Masks on Amazon Following $10M Funding and DARPA Support

Seattle startup Singletto, with $10 million in funding and support from DARPA, has launched FDA-approved virus-neutralizing face masks on Amazon using its Oxafence Active Protection technology that kills 99.9% of certain viruses. The masks are the only FDA-cleared products in the U.S. that inactivate tested viruses and may have applications in healthcare and national security.

Seattle Startup Boundless Acquires Berlin's Localyze to Expand Global Immigration Services Amid U.S. Policy Crackdown

Seattle startup Boundless Immigration has acquired Berlin-based Localyze to expand its immigration services globally amid the Trump administration's tightening of U.S. immigration policies. This acquisition allows Boundless to serve clients immigrating to over 30 countries, simplifying visa processes for corporate clients with international offices.

Pacific Northwest Leads Fusion Energy Efforts with Helion Energy's $1B Project Starting and Zap Energy's Reactor Advances

The Pacific Northwest has become a fusion energy hub, highlighted by Seattle Fusion Week, with key companies like Helion Energy starting commercial fusion plant construction and Zap Energy advancing reactor milestones. Despite technical challenges, regional firms and research institutions continue efforts toward achieving cost-effective fusion power by the late 2020s.

Seattle Startups Yoodli and A-Alpha Bio Appoint New C-Suite Execs, TiE Seattle Names Siddhartha Srinivasa as President

Seattle startups Yoodli, A-Alpha Bio, and MoxiWorks have added senior executives, including Andy Larson as Yoodli's CFO and Troy Lionberger as A-Alpha Bio's chief business officer, while TiE Seattle appointed Siddhartha Srinivasa as president. These moves highlight growth and leadership shifts in the Seattle tech sector, with companies focusing on AI, biotech, and robotics.

Fred Hutch-Led Synthesize Bio Raises $10M to Accelerate Drug Discovery Using AI Gene Expression Model

Seattle-based Synthesize Bio, led by Fred Hutchinson Cancer Center researchers, raised $10 million from Madrona to accelerate drug discovery using their AI model GEM-1, which predicts gene expression outcomes with lab-level accuracy. The startup aims to reduce drug development time and costs by simulating hypothetical lab experiments with generative genomics.

Lila Biologics, Nobel Laureate’s Startup, Partners with Eli Lilly to Develop AI-Based Tumor Therapies

Lila Biologics, a startup from Nobel Laureate David Baker's University of Washington lab, is collaborating with Eli Lilly to develop AI-powered tumor-targeted therapies, aiming to deliver a candidate protein for clinical trials within six months. The startup utilizes AI and machine learning platforms to create therapeutic proteins for targeted radiotherapy and long-acting injectable drugs.

Organizations

  • CoMotion News Reporter · current
  • GeekWire Reporter · current

Online